Rencently, another retrospective cohort study from the Netherlands and Canada on pediatric LCH reported 54 patients with MAP2K1 mutations, 39 with BRAF exon 12 mutations, and 13 with rare BRAF alterations. The gene discussed is BRAF; the disease is Langerhans cell histiocytosis.